RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Exocrine Pancreatic Insufficiency Global Clinical Trials Review, Q1, 2011
Feb 2011 - 35 pages - $1,000
Eurand N.V. (EURX) - Financial and Strategic SWOT Analysis Review
May 2011 - 39 pages - $125
Eurand N.V. (EURX) - Financial and Strategic SWOT Analysis Review
Feb 2011 - 39 pages - $125
Metastatic Pancreatic Cancer - Pipeline Review, Q3 2011
Jul 2011 - 321 pages - $500
US FDA Approval of Afinitor Ends a Three Decade Long Wait for Pancreatic Neuroendocrine Tumor (PNET) Patients
May 2011 - 5 pages - $500
Hepatic Insufficiency Global Clinical Trials Review, Q2, 2011
May 2011 - 50 pages - $1,000
Laboratoires Mayoly Spindler - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Respiratory Insufficiency Global Clinical Trials Review, Q1, 2011
Jan 2011 - 49 pages - $1,000
Altus Pharmaceuticals Inc.: Company Profile and SWOT Analysis
Sep 2011 - 29 pages - $99
AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 26 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Manufacturing del
Therapeutic target
Endocrinology del
Pancreatic exocrine insufficiency del
Year
2011 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us